MAR 28, 2018 06:00 AM PDT

Extraction and the Labeling of Cannabis Products

C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Director and Chief Scientific Officer, Americans For Safe Access
      Jahan Marcu, Ph.D., is currently the Chief Science Officer at Americans for Safe Access (a medical cannabis patient advocacy non-profit) and Director of the Patient Focused Certification program, which is a health and safety oversight program that assesses regulatory compliance at cannabis operations. He is co-founder of the International Research Center on Cannabis and Mental Health and is on the scientific advisory board of the International Cannabis and Cannabinoid Institute (Czech Republic).

      He is also co-founder and past-chairman of the CANN subdivision of the Chemical Health and Safety Division (DCHAS) of the American Chemical Society. His is also on the Board of Directors of the International Association for Cannabinoids as Medicine (Germany). He has a background in analytical chemistry and molecular pharmacology, he received his Ph.D. for contributions in characterizing the structure and function of the cannabinoid receptors. He is an author of the American Herbal Pharmacopeia's Cannabis Monograph and serves on multiple expert government, trade association committees, scientific organizations and is a court-qualified synthetic cannabinoid and cannabis expert. He has helped create the first standards for the medical cannabis industry with the American Herbal Products Association, as well as related educational training for clinicians and workers in the industry. He has been invited to speak at many international conferences, universities, hospitals, including the University of Leiden, Temple University School of Medicine, Princeton Hospital, and Yale University. Dr. Marcu is a recipient of the Billy Martin research award from the International Cannabinoid Research Society.


    There is growing consumer and patient demand for products containing cannabidiol (CBD) and other constituents of the cannabis plant, due to their purported medicinal benefits for a myriad of health conditions. Quality control laboratories provide important ancillary services for the medical cannabis industry in the United States. Method development for cannabis analysis is on-going in the industry due to increasing demands on laboratories to produce accurate results in a timely and inexpensive manner.

    This presentation will discuss various cannabis extractions methods for producing different products, as well as the effects of sample preparation and analysis on the labeling of these product. Results from analyzing cannabis products and the accuracy of their labels will be discussed. Data from analyzing cannabis samples, extracts, and concentrates will be shared. Lastly, the role of training and 3rd party product certification for health and safety standards will be discussed as one potential solution to the public health issues facing the cannabis industry.

    Learning Objectives:

    • Be able to describe and compare the benefits and drawbacks of different extraction methods
    • Be able to examine and assess cannabis products based on labeling and other product information



    Show Resources
    Loading Comments...